Rating History for BioMarin Pharmaceutical Inc. (BMRN) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/12/2026 | Chris Raymond | Upgrade | Strong Buy (Outperform) |
109.00 (N/A) |
54.80 (55.95) |
2.1% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
